Literature DB >> 8093827

A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.

H Kreipe1, H J Heidebrecht, S Hansen, W Röhlk, M Kubbies, H H Wacker, M Tiemann, H J Radzun, R Parwaresch.   

Abstract

A monoclonal antibody (Ki-S1) has been raised that reacts with the nuclei of proliferating cells. The antigen recognized is resistant to formalin fixation and can be detected in frozen tissues as well as in routinely processed specimens. In immunohistochemistry, nuclear staining can be seen in those tissues and cellular compartments known to be actively proliferating. Peripheral blood lymphocytes are negative but show a strong increase in antigen expression after mitogen stimulation. Flow cytometric determination of DNA content and antigen expression revealed negativity of G0 cells and positivity of G1 to G2/M cells. A cytoplasmic co-reactivity, not associated with proliferation, was confined to Langerhans islands of the pancreas. The nuclear localized antigen has a molecular mass of 160 kd and therefore seems to be different from all other known immunohistochemical markers of proliferating cells. We conclude that the monoclonal antibody Ki-S1 might provide a useful tool for studying cell proliferation in situ under normal and pathological circumstances.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093827      PMCID: PMC1886851     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.

Authors:  G Landberg; G Roos
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

Review 2.  Monoclonal antibody Ki-67: its use in histopathology.

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

3.  Complex Ca2+ flux inhibition as primary mechanism of staurosporine-induced impairment of T cell activation.

Authors:  M Kubbies; B Goller; E Russmann; H Stockinger; W Scheuer
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

4.  How should we count AgNORS? Proposals for a standardized approach.

Authors:  J Crocker; D A Boldy; M J Egan
Journal:  J Pathol       Date:  1989-07       Impact factor: 7.996

5.  The cell cycle associated change of the Ki-67 reactive nuclear antigen expression.

Authors:  K Sasaki; T Murakami; M Kawasaki; M Takahashi
Journal:  J Cell Physiol       Date:  1987-12       Impact factor: 6.384

6.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

Review 7.  Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal.

Authors:  L G Koss; B Czerniak; F Herz; R P Wersto
Journal:  Hum Pathol       Date:  1989-06       Impact factor: 3.466

8.  Ki-B5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic human B cells in routine paraffin sections.

Authors:  M L Hansmann; H H Wacker; J Gralla; H Lumbeck; M Kossmahl; H J Heidebrecht; H J Radzun; M R Parwaresch
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

9.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

Authors:  H G Gratzner
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

View more
  19 in total

1.  Testicular juvenile granulosa cell and Sertoli cell tumours: a clinicopathological study of 29 cases from the Kiel Paediatric Tumour Registry.

Authors:  D Harms; L R Kock
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.

Authors:  F Boege; A Andersen; S Jensen; R Zeidler; H Kreipe
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 3.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

4.  Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.

Authors:  U Lehmann; S Glöckner; W Kleeberger; H F von Wasielewski; H Kreipe
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  A closer look at the cell cycle.

Authors:  H Kreipe; R Parwaresch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  Bone marrow tissue and proliferation markers: results and general problems.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.

Authors:  H Kreipe; H H Wacker; H J Heidebrecht; K Haas; M Hauberg; M Tiemann; R Parwaresch
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

Review 8.  Primary non-Hodgkin's lymphoma of the vagina. Case report and review of the literature.

Authors:  H G Höffkes; A Schumann; M Uppenkamp; C Teschendorf; A E Schindler; R Parwaresch; G Brittinger
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

9.  Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2.

Authors:  Elizabeth A Salisbury; Zawaunyka W Lazard; Eroboghene E Ubogu; Alan R Davis; Elizabeth A Olmsted-Davis
Journal:  Stem Cells Transl Med       Date:  2012-11-26       Impact factor: 6.940

10.  The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.

Authors:  A Claviez; M Tiemann; J Peters; H Kreipe; R Schneppenheim; R Parwaresch
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.